(CNN)-- The controversial drug Avastin should be phased out as a treatment for metastatic breast cancer, the Food and Drug Administration said Thursday, citing recent studies that show its ...

Call your doctor right away if you have any serious side effects during treatment with Avastin. If the side effects seem life threatening or you think you’re having a medical emergency ...

Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

Amgen and Allergan’s biosimilar of Roche’s cancer blockbuster Avastin has been approved in the EU, but there could be a four-year wait before the drug makes it to the market. The patent ...

The experimental therapy demonstrated a safety profile ... a six-month survival advantage with cancer drugs atezolizumab and bevacizumab, marketed as Tecentriq and Avastin by Roche (OTCQX:RHHBY ...